-
-
-
-
-
Address *
-
-
1. Is the Material to be transferred a: compound, hybridoma or a sample of human tissue? *
-
2. Is there a fee being charged for the Material? *
-
-
3. Was the Material generated outside of Newcastle University? (eg at another University). *
-
-
4. Are the materials coming out of a Biobank and if so, which one? *
-
-
5. Was the Material, or any component part of the Material (e.g. the original cell line if transferring an engineered cell line) obtained under another contract? (e.g. under an MTA or a contract for receipt of a cell line) *
-
-
6. Is the proposed transfer to a company (eg a pharma company) or an organisation working with a company (eg a research institute to carry out contract research or research in collaboration with industry)? *
-
-
-
8. Is the transfer for collaborative purposes? (eg where you want access to the results). *
-
-
-
10. Has the Material been commercialised or is in the process of being commercialised, or does the Material have commercial potential? (eg is there a patent application associated with the Material or has the Material been licensed or otherwise provided to a company already). *
-
-
-
Please enter today's date. *
/
/
-
Please enter your email address. You will receive a copy of the submission for your records.
-
-
I confirm that I am the Principal Investigator named above or another individual submitting on the authority of the Principal Investigator named above. *
-
Data Protection Statement
Please Note
The information provided above will be specifically used for the negotiation of suitable contract terms with the parties named in the above questionnaire.
The University’s Data Protection Policy can be found at:
https://newcastle.sharepoint.com/docs/Information%20Data%20and%20IT%20Policies/Forms/AllItems.aspx?id=%2Fdocs%2FInformation%20Data%20and%20IT%20Policies%2FData%20Protection%20Policy%20Jan%202019%2Epdf&parent=%2Fdocs%2FInformation%20Data%20and%20IT%20Policies
-